Literature DB >> 10392655

Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli.

E Gahtan1, J B Overmier.   

Abstract

Experimental evidence from molecular biology, biochemistry, epidemiology and behavioral research support the conclusion that brain inflammation contributes to the pathogenesis of Alzheimer's disease and other types of human dementias. Aspects of neuroimmunology relating to the pathogenesis of Alzheimer's disease are briefly reviewed. The effects of brain inflammation, mediated through cytokines and other secretory products of activated glial cells, on neurotransmission (specifically, nitric oxide, glutamate, and acetylcholine), amyloidogenesis, proteolysis, and oxidative stress are discussed within the context of the pathogenesis of learning and memory dysfunction in Alzheimer's disease. Alzheimer's disease is proposed to be an etiologically heterogeneous syndrome with the common elements of amyloid deposition and inflammatory neuronal damage.

Entities:  

Mesh:

Year:  1999        PMID: 10392655     DOI: 10.1016/s0149-7634(98)00058-x

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  21 in total

Review 1.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes.

Authors:  Gary A Weisman; M Wang; Q Kong; N E Chorna; J T Neary; Grace Y Sun; Fernando A González; C I Seye; L Erb
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.

Authors:  Monica Marchese; David Cowan; Elizabeth Head; Donglai Ma; Khalil Karimi; Vanessa Ashthorpe; Minesh Kapadia; Hui Zhao; Paulina Davis; Boris Sakic
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats.

Authors:  Giulia D'Intino; Michela Paradisi; Mercedes Fernandez; Alessandro Giuliani; Luigi Aloe; Luciana Giardino; Laura Calzà
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 5.  P2Y2 nucleotide receptor-mediated responses in brain cells.

Authors:  Troy S Peterson; Jean M Camden; Yanfang Wang; Cheikh I Seye; W G Wood; Grace Y Sun; Laurie Erb; Michael J Petris; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2010-04-13       Impact factor: 5.590

Review 6.  Alzheimer's disease, brain immune privilege and memory: a hypothesis.

Authors:  Y I Arshavsky
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

7.  Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

Authors:  N Rösler; I Wichart; K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

8.  Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity.

Authors:  A Law; S Gauthier; R Quirion
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

9.  Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation.

Authors:  A Abdi; H Sadraie; L Dargahi; L Khalaj; A Ahmadiani
Journal:  Neurochem Res       Date:  2010-09-17       Impact factor: 3.996

Review 10.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.